Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · IEX Real-Time Price · USD
7.65
-0.24 (-3.04%)
At close: Apr 17, 2024, 4:00 PM
7.89
+0.24 (3.14%)
After-hours: Apr 17, 2024, 6:24 PM EDT
Ironwood Pharmaceuticals Market Cap
Ironwood Pharmaceuticals has a market cap or net worth of $1.20 billion as of April 18, 2024. Its market cap has decreased by -27.61% in one year.
Market Cap
1.20B
Enterprise Value
1.82B
1-Year Change
-27.61%
Ranking
Category
Stock Price
$7.65
Market Cap Chart
Since February 3, 2010, Ironwood Pharmaceuticals's market cap has increased from $1.11B to $1.20B, an increase of 8.30%. That is a compound annual growth rate of 0.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 16, 2024 | 1.24B | 1.28% |
Apr 15, 2024 | 1.22B | -1.14% |
Apr 12, 2024 | 1.23B | -1.63% |
Apr 11, 2024 | 1.25B | 0.25% |
Apr 10, 2024 | 1.25B | -0.99% |
Apr 9, 2024 | 1.26B | 0.62% |
Apr 8, 2024 | 1.26B | -0.49% |
Apr 5, 2024 | 1.26B | -1.11% |
Apr 4, 2024 | 1.28B | 0.50% |
Apr 3, 2024 | 1.27B | -1.34% |
Apr 2, 2024 | 1.29B | -4.53% |
Apr 1, 2024 | 1.35B | -1.15% |
Mar 28, 2024 | 1.36B | 1.04% |
Mar 27, 2024 | 1.35B | 3.61% |
Mar 26, 2024 | 1.30B | -1.07% |
Mar 25, 2024 | 1.32B | -3.11% |
Mar 22, 2024 | 1.36B | -3.88% |
Mar 21, 2024 | 1.41B | -0.88% |
Mar 20, 2024 | 1.43B | 2.94% |
Mar 19, 2024 | 1.39B | 3.99% |
Mar 18, 2024 | 1.33B | -5.65% |
Mar 15, 2024 | 1.41B | 0.56% |
Mar 14, 2024 | 1.40B | 3.82% |
Mar 13, 2024 | 1.35B | -0.57% |
Mar 12, 2024 | 1.36B | -2.91% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Verona Pharma | 1.28B |
AbCellera Biologics | 1.27B |
Xencor | 1.25B |
Omnicell | 1.25B |
Pacira BioSciences | 1.25B |
Brookdale Senior Living | 1.23B |
Kiniksa Pharmaceuticals | 1.22B |
Deciphera Pharmaceuticals | 1.22B |